Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions

Journal of the American Academy of Dermatology
Julia S Lehman, Amer N Kalaaji

Abstract

The incidence of pneumocystis pneumonia (PCP), an opportunistic infection caused by Pneumocystis jiroveci, in patients taking immunosuppressive medications for dermatologic indications is unknown. We sought to define the incidence of PCP in patients with dermatologic conditions, to characterize risk factors for PCP development in these patients, to examine PCP prophylaxis practices among dermatologists, and to document adverse effects of PCP prophylaxis medications. We reviewed the medical records of patients taking immunosuppressive medications for longer than 1 month who were treated for dermatologic conditions between 1998 and 2007 at Mayo Clinic, Rochester, MN. Of 198 patients meeting inclusion criteria (150 [75.8%] of whom received no PCP prophylaxis), one patient (0.5% and 0.7%, respectively) had PCP that developed during the follow-up period. In this patient, a 94-year-old woman with bullous pemphigoid, severe interstitial pulmonary fibrosis, aortic stenosis, and hypoalbuminemia, PCP developed within 7 months of diagnosis and was treated with methotrexate and prednisone. She had not received PCP prophylaxis. Only 6 patients (3%) with dermatology as their primary service received PCP prophylaxis. Overall, rates of adverse...Continue Reading

References

Feb 12, 1992·JAMA : the Journal of the American Medical Association·K A SepkowitzD Armstrong
Jun 1, 1994·Annals of Internal Medicine·J E GallantR E Chaisson
Dec 3, 1999·The British Journal of Dermatology·S P Raychaudhuri, S Siu
Jul 9, 2002·The British Journal of Dermatology·H McGarry, J McLelland
Dec 8, 2004·Journal of Gastroenterology·Ryuta TakenakaYasushi Tanimoto
Jul 16, 2005·Revista Do Instituto De Medicina Tropical De São Paulo·Luiz Sergio AzevedoElias David-Neto
Nov 23, 2005·Revista Do Instituto De Medicina Tropical De São Paulo·Anne TotetGilles Nevez
Jun 7, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Jian LiXue-Jun Zeng
Jun 20, 2006·Journal of the American Academy of Dermatology·Chad M LemaireSylvia Hsu
Apr 28, 2007·Scandinavian Journal of Infectious Diseases·Umut KalyoncuA Ihsan Ertenli
Sep 19, 2007·Archives of Dermatology·Mandi L MaronnBeth A Drolet
Oct 16, 2009·Journal of the American Academy of Dermatology·Jacqueline L Gerhart, Amer N Kalaaji

❮ Previous
Next ❯

Citations

May 13, 2014·Journal of the American Academy of Dermatology·Yael A LeshemDaniel Mimouni
Nov 9, 2016·American Journal of Clinical Dermatology·Yael A LeshemDaniel Mimouni
Dec 26, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Thomas G CotterDarrell S Pardi
Mar 13, 2018·The Journal of Dermatological Treatment·Daphne S BakkerMarjolein S de Bruin-Weller
Jun 19, 2013·The Journal of Dermatology·Julia S LehmanChristine M Lohse
Mar 9, 2021·Journal of the American Academy of Dermatology·Carmen M MontagnonStanislav N Tolkachjov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Benjamin A Lipsky, Christopher Hoey
International Journal of Dermatology
V RuoccoA Baroni
© 2021 Meta ULC. All rights reserved